Consumption of soy products has been linked to a reduced mortality and morbidity from a number of cancers. Genistein, one of the principal soy isoflavones, has been shown to inhibit the growth of a number of tumour cell lines in vitro; however, a role of genistein in retarding tumour growth in vivo
Facilitation and inhibition of B16 melanoma by BCG in vivo and by lymphoid cells from BCG-treated mice in vitro
✍ Scribed by D. O. Chee; A. J. Bodurtha
- Publisher
- John Wiley and Sons
- Year
- 1974
- Tongue
- French
- Weight
- 443 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Groups of mice were pretreated with varying dosages of BCG, then injected with B16 melanoma cells. In mice pretreated with high‐dose (0.5 mg) BCG, the tumor grew at an accelerated rate, whereas with low‐dose (0.005 mg) BCG, the tumor grew at a reduced rate when compared to growth in control mice. These data show that BCG could, depending upon dosage, either facilitate or inhibit tumor growth in vivo. Furthermore, lymphoid cells from high‐dose BCG‐treated tumor‐bearing mice were stimulatory to target B16 melanoma cells in vitro if the ratio of lymphoid cells to target tumor cells was sufficiently low (25:1‐200:1), but were inhibitory when the ratio was high (400:1‐1,000:1).
📜 SIMILAR VOLUMES
## Abstract The cell cycle regulatory pathway responsible for the control of the late‐G1 checkpoint is found recurrently altered in human malignant melanoma, often due to lack of functional p16 or pRb (pRb‐1) proteins. Here we examined the ability of p16‐derived peptides to mimic p16 function in tw
In this work we have assessed the effect of cell surface anti-immunoglobulin (Ig) of anti-idiotypic B cells on their idiotypic counterparts in vivo and in vitro, as a surrogate for soluble anti-surface Ig, using the well-characterized anti-arsonate system. The response of A/J mice against the hapten